The U.S. Centers for Medicare & Medicaid Services (CMS) Tuesday asked the White House to review a hospital payment proposed rule for next year that will either keep, end, or change the nearly 30 percent cut since 2018 in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs.
CMS on May 11 sent its calendar year 2022 hospital outpatient prospective payment (OPPS) payment rates and policy changes proposed rule to the Office of Management and Budget (OMB) for approval to be published in the Federal Register. Compared with recent years’ OPPS proposed rules, OMB is getting this one from CMS for review sooner than normal. Last year, CMS released the calendar year 2021 proposed rule for public comment on Aug. 4. Signs point to the new proposed rule being released in July.
The U.S. Centers for Medicare & Medicaid Services (CMS) Tuesday asked the White House to review a hospital payment proposed rule for next year that will either keep, end, or change the nearly 30 percent cut since 2018 in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.